|
||||||
|
|
|
|
|
|
|
| Steven D Wexner, MD Chief, Division of Colorectal Surgery Cleveland Clinic Florida Weston, Florida Neal J Meropol, MD Director, Gastrointestinal Cancer Program Director, Gastrointestinal Tumor Risk Assessment Program Divisions of Medical Science and Population Science Fox Chase Cancer Center Philadelphia, Pennsylvania |
Mark S Roh, MD Chair, Department of Surgery, Allegheny General Hospital Director, Division of Surgical Oncology Professor, Human Oncology Drexel University College of Medicine Pittsburgh, Pennsylvania Paulo M Hoff, MD Executive Director Hospital Sirio Libanes São Paulo, Brazil |
CONTENT VALIDATION AND DISCLOSURES
Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Chris Thomson, MD, MS, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech Inc. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Genentech Inc/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.
In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:
Dr Wexner — Consulting Fees: Baxter International Inc, Boston Scientific Corporation, Curon Medical Inc, Incontinence Devices Inc, Power Medical Interventions Inc; Grants/Research Support: Curon Medical Inc, Ethicon Inc, Ethicon Endo-Surgery Inc, Incontinence Devices Inc, Karl Storz Endoscopy-America Inc, Medtronic Inc, National Institutes of Health, SurgRx Inc; Stock Options: Intuitive Surgical Inc, MedSurge Medical Inc, Power Medical Interventions Inc; Scientific Advisory Board Member: CB Fleet Company Inc. Dr Meropol — Consulting Fees: Amgen Inc, Genentech Inc, Pfizer Inc. Dr Roh — No financial interests or affiliations to disclose. Dr Hoff— Contracted Research: Amgen Inc, Genentech Inc, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis.
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.
